相关实验视频

Updated: Sep 16, 2025

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

MTHFD1L是一种新的预后标志物和治疗点,用于皮肤黑色素瘤

Xinlian Xie¹, Guangfu Shi¹, Kebin Ning¹

¹Department of Bone and Soft Tissue Surgery, Guangxi Medical University Cancer Hospital, Hedi Rd. #71, Nanning, 530021, Guangxi, China.

Diagnostic pathology

|July 10, 2025

概括

甲基酸脱酶1-样 (MTHFD1L) 在皮肤皮肤黑色素瘤 (SKCM) 中被上调,并与较差的生存率有关. 抑制MTHFD1L抑制了黑色素瘤细胞的生长和入侵,这表明它是治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

皮肤皮肤黑色素瘤 (SKCM) 是一种高度恶性瘤.
在SKCM中MTHFD1L的生物学意义需要进一步调查.

研究的目的:

为了研究皮肤黑色素瘤中MTHFD1L的表达水平.
揭示MTHFD1L在SKCM中的潜在生物学意义和治疗价值.

主要方法:

使用TCGA-SKCM,GSE15605和GSE19234数据集进行MTHFD1L表达式分析.
进行生物信息学分析,包括GO/KEGG丰富,PPI网络和免疫透相关性.
在黑色素瘤细胞系中使用RT-qPCR,西斑,IHC和MTHFD1L敲除进行实验验证.

主要成果:

在SKCM组织中,MTHFD1L表达升高,与整体存活率差相关.
抑制MTHFD1L显著抑制了黑色素瘤细胞的增殖,迁移,入侵和克隆性潜力.
研究结果表明,MTHFD1L可能调节黑色素瘤中的TGF-β/SMAD信号通路.

结论:

MTHFD1L被确定为皮肤黑色素瘤的潜在生物标志物.
MTHFD1L为治疗SKCM提供了潜在的治疗点.

关键词:

皮肤黑色素瘤是一种皮肤黑色素瘤.MTHFD1LL 在线观看预测值的预测值是指预测值的预测值.在TGF-β/SMAD信号通路中.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...